Impaired attention in the 3xTgAD mouse model of Alzheimer's disease: Rescue by donepezil (Aricept)

Journal of Neuroscience

Volumn 31, Issue 9, 2011, Pages 3500-3507

  Romberg, Carola ^a   Mattson, Mark P ^c   Mughal, Mohamed R ^c   Bussey, Timothy J ^a,b   Saksida, Lisa M ^a,b  

^a UK   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; DONEPEZIL; METHIONINE; PRESENILIN 1; TAU PROTEIN; VALINE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; DISEASE MODEL; EMBRYO; FEMALE; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REACTION TIME; STIMULUS RESPONSE; TASK PERFORMANCE; TREATMENT OUTCOME; WILD TYPE;

ALZHEIMER DISEASE; ANIMALS; ATTENTION; CONDITIONING, OPERANT; DISEASE MODELS, ANIMAL; HUMANS; INDANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PIPERIDINES;

EID: 79952260574     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.5242-10.2011     Document Type: Article

References (72)

1. Artero S, Ritchie K (2003) The detection of mild cognitive impairment in the general practice setting. Aging Ment Health 7:251-258. (Pubitemid 36917123)
2. Baddeley A, Cocchini G, Della Sala S, Logie RH, Spinnler H (1999) Working memory and vigilance: evidence from normal aging and Alzheimer's disease. Brain Cogn 41:87-108. (Pubitemid 29487530)
3. Baddeley AD, Baddeley HA, Bucks RS, Wilcock GK (2001) Attentional control in Alzheimer's disease. Brain 124:1492-1508. (Pubitemid 32726764)
4. Balducci C, Nurra M, Pietropoli A, Samanin R, Carli M (2003) Reversal of visual attention dysfunction after AMPA lesions of the nucleus basalis magnocellularis (NBM) by the cholinesterase inhibitor donepezil and by a 5-HT1A receptor antagonist WAY 100635. Psychopharmacology (Berl) 167:28-36. (Pubitemid 36535289)
5. Bartko SJ, Vendrell I, Saksida LM, Bussey TJ (2010) A computer-automated touchscreen paired-associates learning (PAL) task for mice: impairments following administration of scopolamine or dicyclomine and improvements following donepezil. Psychopharmacology (Berl). Advance online publication. Retrieved November 18, 2010. doi:10.1007/s00213-010-2050-1.
6. Bentley P, Vuilleumier P, Thiel CM, Driver J, Dolan RJ (2003) Cholinergic enhancement modulates neural correlates of selective attention and emotional processing. Neuroimage 20:58-70. (Pubitemid 37188499)
7. Bentley P, Driver J, Dolan RJ (2008) Cholinesterase inhibition modulates visual and attentional brain responses in Alzheimer's disease and health. Brain 131:409-424. (Pubitemid 351197610)
8. Berardi AM, Parasuraman R, Haxby JV (2005) Sustained attention in mild Alzheimer's disease. Dev Neuropsychol 28:507-537. (Pubitemid 41060189)
9. Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM (2005) Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 45:675-688. (Pubitemid 40320703)
10. Blin J, Ivanoiu A, De Volder A, Michel C, Bol A, Verellen C, Seron X, Duprez T, Laterre EC (1998) Physostigmine results in an increased decrement in brain glucose consumption in Alzheimer's disease. Psychopharmacology (Berl) 136:256-263. (Pubitemid 28143175)
11. Blondel A, Sanger DJ, Moser PC (2000) Characterisation of the effects of nicotine in the five-choice serial reaction time task in rats: antagonist studies. Psychopharmacology (Berl) 149:293-305. (Pubitemid 30262344)
12. Carli M, Robbins TW, Evenden JL, Everitt BJ (1983) Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav Brain Res 9:361-380. (Pubitemid 13002330)
13. Chudasama Y, Muir JL (2001) Visual attention in the rat: a role for the prelimbic cortex and thalamic nuclei? Behav Neurosci 115:417-428.
14. Chudasama Y, Robbins TW (2004) Psychopharmacological approaches to modulating attention in the five-choice serial reaction time task: implications for schizophrenia. Psychopharmacology (Berl) 174:86-98. (Pubitemid 38925094)
15. Chudasama Y, Passetti F, Rhodes SE, Lopian D, Desai A, Robbins TW (2003) Dissociable aspects of performance on the 5-choice serial reaction time task following lesions of the dorsal anterior cingulate, infralimbic and orbitofrontal cortex in the rat: differential effects on selectivity, impulsivity and compulsivity. Behav Brain Res 146:105-119. (Pubitemid 37476138)
16. Dalley JW, McGaughy J, O'Connell MT, Cardinal RN, Levita L, Robbins TW (2001) Distinct changes in cortical acetylcholine and noradrenaline efflux during contingent and noncontingent performance of a visual attentional task. J Neurosci 21:4908-4914. (Pubitemid 32565649)
17. Dalley JW, Theobald DE, Bouger P, Chudasama Y, Cardinal RN, Robbins TW (2004) Cortical cholinergic function and deficits in visual attentional performance in rats following 192 IgG-saporin-induced lesions of the medial prefrontal cortex. Cereb Cortex 14:922-932. (Pubitemid 38971466)
18. Davies P, Maloney AJ (1976) Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2:1403. (Pubitemid 8004505)
19. de Bruin NM, Fransen F, Duytschaever H, Grantham C, Megens AA (2006) Attentional performance of (C57BL/6J x 129Sv)F2 mice in the fivechoice serial reaction time task. Physiol Behav 89:692-703. (Pubitemid 44894253)
20. Dermaut B, Kumar-Singh S, Rademakers R, Theuns J, Cruts M, Van Broeckhoven C (2005) Tau is central in the genetic Alzheimer-frontotemporal dementia spectrum. Trends Genet 21:664-672. (Pubitemid 41608689)
21. Foldi NS, White RE, Schaefer LA (2005a) Detecting effects of donepezil on visual selective attention using signal detection parameters in Alzheimer's disease. Int J Geriatr Psychiatry 20:485-488. (Pubitemid 40716343)
22. Foldi NS, Schaefer LA, White RE, Johnson R Jr, Berger JT, Carney MT, Macina LO (2005b) Effects of graded levels of physical similarity and density on visual selective attention in patients with Alzheimer's disease. Neuropsychology 19:5-17. (Pubitemid 40144308)
23. Francis PT, Palmer AM, Sims NR, Bowen DM, Davison AN, Esiri MM, Neary D, Snowden JS, Wilcock GK (1985) Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment. N Engl J Med 313:7-11. (Pubitemid 15068737)
24. Götz J, Ittner LM (2008) Animal models of Alzheimer's disease and frontotemporal dementia. Nat Rev Neurosci 9:532-544. (Pubitemid 351873467)
25. Grady CL, Haxby JV, Horwitz B, Sundaram M, Berg G, Schapiro M, Friedland RP, Rapoport SI (1988) Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer type. J Clin Exp Neuropsychol 10:576-596.
26. Haass C (1997) Presenilins: genes for life and death. Neuron 18:687-690.
27. Hirata-Fukae C, Li HF, Hoe HS, Gray AJ, Minami SS, Hamada K, Niikura T, Hua F, Tsukagoshi-Nagai H, Horikoshi-Sakuraba Y, Mughal M, Rebeck GW, LaFerla FM, Mattson MP, Iwata N, Saido TC, Klein WL, Duff KE, Aisen PS, Matsuoka Y (2008) Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model. Brain Res 1216:92-103.
28. Huff FJ, Growdon JH, Corkin S, Rosen TJ (1987a) Age at onset and rate of progression of Alzheimer's disease. J Am Geriatr Soc 35:27-30. (Pubitemid 17221847)
29. Huff FJ, Becker JT, Belle SH, Nebes RD, Holland AL, Boller F (1987b) Cognitive deficits and clinical diagnosis of Alzheimer's disease. Neurology 37:1119-1124. (Pubitemid 17123441)
30. Humby T, Laird FM, Davies W, Wilkinson LS (1999) Visuospatial attentional functioning in mice: interactions between cholinergic manipulations and genotype. Eur J Neurosci 11:2813-2823. (Pubitemid 29364198)
31. Jones DN, Higgins GA (1995) Effect of scopolamine on visual attention in rats. Psychopharmacology (Berl) 120:142-149.
32. Jones GM, Sahakian BJ, Levy R, Warburton DM, Gray JA (1992) Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology (Berl) 108:485-494.
33. Kirkby DL, Higgins GA (1998) Characterization of perforant path lesions in rodent models of memory and attention. Eur J Neurosci 10:823-838. (Pubitemid 28375608)
34. Lamar M, Podell K, Carew TG, Cloud BS, Resh R, Kennedy C, Goldberg E, Kaplan E, Libon DJ (1997) Perseverative behavior in Alzheimer's disease and subcortical ischemic vascular dementia. Neuropsychology 11:523-534. (Pubitemid 27459759)
35. Lambourne SL, Humby T, Isles AR, Emson PC, Spillantini MG, Wilkinson LS (2007) Impairments in impulse control in mice transgenic for the human FTDP-17 tauV337M mutation are exacerbated by age. Hum Mol Genet 16:1708-1719. (Pubitemid 47241830)
36. Lawrence AD, Sahakian BJ (1995) Alzheimer disease, attention, and the cholinergic system. Alzheimer Dis Assoc Disord 9 [Suppl 2]:43-49.
37. Levinoff EJ, Saumier D, Chertkow H (2005) Focused attention deficits in patients with Alzheimer's disease and mild cognitive impairment. Brain Cogn 57:127-130. (Pubitemid 40228917)
38. McGaughy J, Dalley JW, Morrison CH, Everitt BJ, Robbins TW (2002) Selective behavioral and neurochemical effects of cholinergic lesions produced by intrabasalis infusions of 192 IgG-saporin on attentional performance in a five-choice serial reaction time task. J Neurosci 22:1905-1913. (Pubitemid 35386309)
39. Mendez MF, Cherrier MM, Perryman KM (1997) Differences between Alzheimer's disease and vascular dementia on information processing measures. Brain Cogn 34:301-310. (Pubitemid 27291112)
40. Mirza NR, Stolerman IP (2000) The role of nicotinic and muscarinic acetylcholine receptors in attention. Psychopharmacology (Berl) 148:243-250. (Pubitemid 30136731)
41. Muir JL, Dunnett SB, Robbins TW, Everitt BJ (1992) Attentional functions of the forebrain cholinergic systems: effects of intraventricular hemicholinium, physostigmine, basal forebrain lesions and intracortical grafts on a multiple-choice serial reaction time task. Exp Brain Res 89:611-622.
42. Muir JL, Everitt BJ, Robbins TW (1994) AMPA-induced excitotoxic lesions of the basal forebrain: a significant role for the cortical cholinergic system in attentional function. J Neurosci 14:2313-2326. (Pubitemid 24108136)
43. Nelson RL, Guo Z, Halagappa VM, Pearson M, Gray AJ, Matsuoka Y, Brown M, Martin B, Iyun T, Maudsley S, Clark RF, Mattson MP (2007) Prophylactic treatment with paroxetine ameliorates behavioral deficits and retards the development of amyloid and tau pathologies in 3xTgAD mice. Exp Neurol 205:166-176. (Pubitemid 46617502)
44. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM (2003a) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39:409-421. (Pubitemid 36937044)
45. Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM (2003b) Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol Aging 24:1063-1070. (Pubitemid 37487883)
46. Oddo S, Caccamo A, Green KN, Liang K, Tran L, Chen Y, Leslie FM, LaFerla FM (2005) Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease. Proc Natl Acad Sci U S A 102:3046-3051. (Pubitemid 40299913)
47. Passetti F, Chudasama Y, Robbins TW (2002) The frontal cortex of the rat and visual attentional performance: dissociable functions of distinct medial prefrontal subregions. Cereb Cortex 12:1254-1268. (Pubitemid 35396963)
48. Patel S, Stolerman IP, Asherson P, Sluyter F (2006) Attentional performance of C57BL/6 and DBA/2 mice in the 5-choice serial reaction time task. Behav Brain Res 170:197-203. (Pubitemid 43732352)
49. Pattij T, Janssen MC, Loos M, Smit AB, Schoffelmeer AN, van Gaalen MM (2007) Strain specificity and cholinergic modulation of visuospatial attention in three inbred mouse strains. Genes Brain Behav 6:579-587. (Pubitemid 47246223)
50. Pekkala S, Albert ML, Spiro A 3rd, Erkinjuntti T (2008) Perseveration in Alzheimer's disease. Dement Geriatr Cogn Disord 25:109-114. (Pubitemid 351196122)
51. Perry EK, Perry RH, Blessed G, Tomlinson BE (1978) Changes in brain cholineterases in senile dementia of Alzheimer type. Neuropathol Appl Neurobiol 4:273-277. (Pubitemid 9001675)
52. Perry RJ, Hodges JR (1999) Attention and executive deficits in Alzheimer's disease. A critical review. Brain 122:383-404. (Pubitemid 29110515)
53. Perry RJ, Hodges JR (2000) Differentiating frontal and temporal variant frontotemporal dementia from Alzheimer's disease. Neurology 54:2277-2284. (Pubitemid 30416278)
54. Perry RJ, Hodges JR (2003) Dissociation between top-down attentional control and the time course of visual attention as measured by attentional dwell time in patients with mild cognitive impairment. Eur J Neurosci 18:221-226. (Pubitemid 36999928)
55. Perry RJ, Watson P, Hodges JR (2000) The nature and staging of attention dysfunction in early (minimal and mild) Alzheimer's disease: relationship to episodic and semantic memory impairment. Neuropsychologia 38:252-271.
56. Piquard A, Lacomblez L, Derouesné C, Siéroff E (2009) Problems inhibiting attentional capture by irrelevant stimuli in patients with frontotemporal dementia. Brain Cogn 70:62-66.
57. Reid W, Broe G, Creasey H, Grayson D, McCusker E, Bennett H, Longley W, Sulway MR (1996) Age at onset and pattern of neuropsychological impairment in mild early-stage Alzheimer disease. A study of a community-based population. Arch Neurol 53:1056-1061. (Pubitemid 26340041)
58. Robbins TW (2002) The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berl) 163:362-380.
59. Robbins TW, Granon S, Muir JL, Durantou F, Harrison A, Everitt BJ (1998) Neural systems underlying arousal and attention. Implications for drug abuse. Ann N Y Acad Sci 846:222-237.
60. Rockwood K, Black SE, Robillard A, Lussier I (2004) Potential treatment effects of donepezil not detected in Alzheimer's disease clinical trials: a physician survey. Int J Geriatr Psychiatry 19:954-960. (Pubitemid 39378290)
61. Sahakian B, Jones G, Levy R, Gray J, Warburton D (1989) The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type. Br J Psychiatry 154:797-800. (Pubitemid 19172212)
62. Sahakian BJ, Coull JT (1993) Tetrahydroaminoacridine (THA) in Alzheimer's disease: an assessment of attentional and mnemonic function using CANTAB. Acta Neurol Scand [Suppl 149]:29-35.
63. Sahakian BJ, Owen AM, Morant NJ, Eagger SA, Boddington S, Crayton L, Crockford HA, Crooks M, Hill K, Levy R (1993) Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB. Psychopharmacology (Berl) 110:395-401. (Pubitemid 23074561)
64. Selkoe DJ (1998) The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol 8:447-453.
65. Tiraboschi P, Hansen LA, Alford M, Masliah E, Thal LJ, Corey-Bloom J (2000) The decline in synapses and cholinergic activity is asynchronous in Alzheimer's disease. Neurology 55:1278-1283.
66. Traykov L, Baudic S, Raoux N, Latour F, Rieu D, Smagghe A, Rigaud AS (2005) Patterns of memory impairment and perseverative behavior discriminate early Alzheimer's disease from subcortical vascular dementia. J Neurol Sci 229-230:75-79. (Pubitemid 40341568)
67. Wang Y, Greig NH, Yu QS, Mattson MP (2009) Presenilin-1 mutation impairs cholinergic modulation of synaptic plasticity and suppresses NMDA currents in hippocampus slices. Neurobiol Aging 30:1061-1068.
68. Welsh KA, Butters N, Hughes JP, Mohs RC, Heyman A (1992) Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's disease. Arch Neurol 49:448-452.
69. Whitehouse PJ, Au KS (1986) Cholinergic receptors in aging and Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 10:665-676. (Pubitemid 17172651)
70. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR (1982) Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215:1237-1239. (Pubitemid 12106486)
71. Yuede CM, Dong H, Csernansky JG (2007) Anti-dementia drugs and hippocampal-dependent memory in rodents. Behav Pharmacol 18:347-363. (Pubitemid 47356364)
72. Zahs KR, Ashe KH (2010) 'Too much good news' - are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer's disease? Trends Neurosci 33:381-389.